logo
Five drugs fail quality test in Chhattisgarh as crackdown on narcotics, tobacco continues

Five drugs fail quality test in Chhattisgarh as crackdown on narcotics, tobacco continues

Time of India2 days ago

RAIPUR: Five drug samples collected from various districts in Chhattisgarh have been declared substandard following inspections by the Food and Drug Administration and subsequent laboratory testing.
This comes as part of an ongoing drive to ensure that quality medicines are available to the public.
According to departmental sources, 34 drug samples were collected from districts including Raipur, Bilaspur, Durg, Sakti, Rajnandgaon, Kondagaon, and Surajpur. These samples were sent to the State Drug Testing Laboratory in Raipur. After testing in May 2025, three medicines were found to have failed to meet quality standards.
The substandard drugs include Vildamed Tablet (Batch No. VGT 242068A), manufactured by Vrindavan Global, Solan, Himachal Pradesh; Rifliwe M Tablet (Batch No. HG 24080598), manufactured by I Heal Pharmaceuticals, Baddi, Himachal Pradesh; and Donlocare DS Suspension (Batch No. DCN-002), manufactured by Quixotic Pharma, Mohali, Punjab.
These medicines are commonly used to treat diabetes, fever, and infections.
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Alarma con cerradura inteligente gratis en Cádiz, instalación en un día
Securitas Direct Alarma
Ver oferta
Undo
The department is taking action against the concerned manufacturers and distributors in accordance with regulations, said a departmental spokesperson.
State Health Minister Shyam Bihari Jaiswal stated, 'There will be no compromise with public health. Strict action will be taken against those selling or distributing substandard medicines. Our government is committed to ensuring high-quality healthcare services in the state.
All drug retailers have been instructed to sell only recognised and certified medicines.'
In a related development, teams of drug inspectors are conducting continuous raids on medical stores across the state to prevent the misuse of narcotic drugs. Work is also progressing rapidly to equip all medical establishments with CCTV cameras, as per government directives.
The Food and Drug Administration has appealed to the public to check the quality and expiry date of medicines before purchasing and to report any suspicious drugs to the department.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tomato recall hits US: FDA warns products sold in these 3 states may be deadly
Tomato recall hits US: FDA warns products sold in these 3 states may be deadly

Hindustan Times

time2 days ago

  • Hindustan Times

Tomato recall hits US: FDA warns products sold in these 3 states may be deadly

Two kinds of tomatoes have been taken off the shelves in 14 states in the US because officials fear they might have salmonella, according to the FDA. The Food and Drug Administration (FDA) initially issued a recall on 2 May, but the situation has since escalated. On 28 May, the agency officially classified it as a Class I recall. FDA says the affected tomatoes were sold in just three states: Georgia, North Carolina, and South Carolina. That's where the potentially contaminated produce was distributed between 23 April and 28 April under the H&C Farms Label, according to the FDA. ALSO READ| Tomatoes recalled across 14 US states due to possible salmonella contamination The tomatoes were packaged and shipped by Williams Farms Repack LLC, a company based in Lodge, South Carolina. While there have been no reported illnesses or deaths as of now, federal officials are urging caution. 'Freezing and drying may prevent the growth of bacteria, but do not kill salmonella,' the FDA explained. 'The bacteria can live for several weeks in dry environments and for several months in wet environments.' 5x6; R4467 6x6; R4467 and R4470 Combo, 25 pound; R4467 4x4, 2-layer; R4467 4x5, 2-layer; R4467 60-count, 2-layer; R4467 60-count, 18 pounds loose; R4467, R4470 XL, 18 pounds loose; R4467 3 count trays; R4467 'The FDA is urging anyone who bought the recalled tomatoes not to eat them and return them to the place of purchase for a full refund, or they can just discard the affected item,' the FDA said. ALSO READ| Who is David Richardson? FEMA head under fire for saying he 'didn't know US had a hurricane season' Centers for Disease Control and Prevention (CDC) says it's a harmful organism that can trigger diarrhea, fever, and abdominal cramps, usually within 12 to 72 hours of consumption. While most people recover without medical help, 'salmonella can cause serious and fatal infections in children, the elderly, and other people with weakened immune systems.' Pregnant women are also at risk. 'Consumers who ate the affected tomatoes and have symptoms should contact their health care provider to report their symptoms,' the FDA added.

Another person with Covid-19 dies, 483 active cases In Del
Another person with Covid-19 dies, 483 active cases In Del

Time of India

time2 days ago

  • Time of India

Another person with Covid-19 dies, 483 active cases In Del

Delhi records fourth Covid death this yr Delhi recorded the death of one more person with Covid-19, taking the city's toll to four this year. One death each was also reported from TN, Maharashtra and Kerala on Monday, reports Anuja Jaiswal. As per MHA's Covid-19 dashboard, Delhi's latest casualty was a woman (22) with a history of pulmonary Koch's disease, tuberculosis and bilateral lower respiratory tract infection. Active cases in Delhi now stand at 483, with 47 new infections since Sunday. Nationwide, the active caseload is 3,961 - Kerala leads with 1,435 followed by Maharashtra with 506. India has seen 32 Covid-19 deaths since Jan. Health experts say while the surge is not leading to severe symptoms, rising numbers do highlight the need for a preventive protocol to check cases. Another person with Covid-19 dies, 483 active cases In Del | page 5 New Delhi: One more person with Covid-19 died in Delhi, taking the death count to four this year so far. The city registered 47 new infections since Sunday, with active cases currently at 483. The nationwide active case count rose to 3,961. Kerala leads with 1,435 active Covid-19 cases, with Maharashtra and Delhi following at 506 and 483 cases, respectively. Since Jan this year, India has recorded 32 Covid-19 related deaths, including four since Sunday, June 1. Besides Delhi, Tamil Nadu, Maharashtra and Kerala each recorded one Covid-19 death since Sunday. According to Union health ministry's Covid-19 dashboard on Monday, the latest casualty was a 22-year-old woman who was previously treated for pulmonary Koch's disease, post-tuberculosis lung condition and bilateral lower respiratory tract infection. Health experts indicate that while current figures remain considerably lower than previous surges, the rising numbers highlight the importance of maintaining preventive health protocols. Meanwhile, the Food and Drug Administration approved the new vaccine for individuals aged 65 and above, as well as people between 12 and 64 years who have at least one health condition increasing their coronavirus risk. Dr Rommel Tickoo, director of internal medicine at Max Hospital Saket, stated that India's current case numbers did not warrant immediate vaccination. He suggested that vulnerable groups might need it eventually, but not the general population. He added that authorities would assess further steps if cases rise.

Another Person With Covid-19 Dies, 483 Active Cases In Delhi
Another Person With Covid-19 Dies, 483 Active Cases In Delhi

Time of India

time2 days ago

  • Time of India

Another Person With Covid-19 Dies, 483 Active Cases In Delhi

New Delhi: One more person with Covid-19 died in Delhi, taking the death count to four this year so far. The city registered 47 new infections since Sunday, with active cases currently at 483. The nationwide active case count rose to 3,961. Kerala leads with 1,435 active Covid-19 cases, with Maharashtra and Delhi following at 506 and 483 cases, respectively. Since Jan this year, India has recorded 32 Covid-19 related deaths, including four since Sunday, June 1. Besides Delhi, Tamil Nadu, Maharashtra and Kerala each recorded one Covid-19 death since Sunday. According to the Union health ministry's Covid-19 dashboard on Monday, the latest casualty was a 22-year-old woman who was previously treated for pulmonary Koch's disease, post-tuberculosis lung condition and bilateral lower respiratory tract infection. Health experts indicate that while current figures remain considerably lower than previous surges, the rising numbers highlight the importance of maintaining preventive health protocols. Meanwhile, the Food and Drug Administration approved the new vaccine for individuals aged 65 and above, as well as people between 12 and 64 years who have at least one health condition increasing their coronavirus risk. Dr Rommel Tickoo, director of internal medicine at Max Hospital Saket, stated that India's current case numbers did not warrant immediate vaccination. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Free P2,000 GCash eGift UnionBank Credit Card Apply Now Undo He suggested that vulnerable groups might need it eventually, but not the general population. He added that authorities would assess further steps if cases rise. Individual vaccination decisions should be made in consultation with healthcare providers, considering personal health status and risk factors. The chairman of PSRI Institute of Pulmonary, Critical Care and Sleep Medicine, Dr GC Khilnani, explained that immunity varies based on previous infections and vaccinations. Both natural Covid immunity post-infection and vaccine-induced protection diminish gradually. While vaccines effectively prevented severe illness, reduced hospitalisations, ICU requirements and deaths, they did not stop transmission. Current mild infections do not warrant concern. However, vulnerable groups, including immunocompromised individuals, those over 75, chemotherapy patients, people with uncontrolled diabetes and long-term steroid users, face elevated risks and should take extra precautions. Dr Suranjit Chatterjee, senior consultant of internal medicine at Indraprastha Apollo Hospitals, recommends ensuring proper indoor ventilation and isolation when unwell. He stated, "People with weak immune systems must exercise caution and follow Covid-19 guidelines strictly. Using face masks in confined, packed or inadequately ventilated areas helps prevent virus spread, especially while travelling in public vehicles, visiting medical facilities and attending gatherings. Regular hand cleaning offers vital protection; keep sanitiser handy and clean hands often. Those experiencing mild discomfort such as sore throat or tiredness should stay home and opt for self-testing."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store